Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787

Aulma R. Parker, Pavankumar N. Petluru, Vicki L. Nienaber, John Badger, Betsy D. Leverett, Kamwing Jair, Vandana Sridhar, Cheyenne Logan, Philippe Y. Ayala, Harry Kochat, Frederick H. Hausheer

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Glutaredoxin (Grx), peroxiredoxin (Prx), and thioredoxin (Trx) are redoxin family proteins that catalyze different types of chemical reactions that impact cell growth and survival through functionally distinct intracellular pathways. Much research is focused on understanding the roles of these redoxin proteins in the development and/or progression of human diseases. Grx and Prx are overexpressed in human cancers, including human lung cancers. BNP7787 is a novel investigational agent that has been evaluated in previous clinical studies, including non-small cell lung cancer (NSCLC) studies. Herein, data from activity assays, mass spectrometry analyses, and X-ray crystallographic studies indicate that BNP7787 forms mixed disulfides with select cysteine residues on Grx and Prx and modulates their function. Studies of interactions between BNP7787 and Trx have been conducted and reported separately. Despite the fact that Trx, Grx, and Prx are functionally distinct proteins that impact oxidative stress, cell proliferation and disease processes through different intracellular pathways, BNP7787 can modify each protein and appears to modulate function through mechanisms that are unique to each target protein. Tumor cells are often genomically heterogeneous containing subpopulations of cancer cells that often express different tumor-promoting proteins or that have multiple dysregulated signaling pathways modulating cell proliferation and drug resistance. A multi-targeted agent that simultaneously modulates activity of proteins important in mediating cell proliferation by functionally distinct intracellular pathways could have many potentially useful therapeutic applications.

Original languageEnglish (US)
Pages (from-to)4928-4950
Number of pages23
JournalMolecules
Volume20
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Glutaredoxins
Peroxiredoxins
cysteine
disulfides
Disulfides
Cysteine
proteins
Thioredoxins
Cell proliferation
cancer
Proteins
Cells
Cell Proliferation
lungs
Tumors
Neoplasms
tumors
Oxidative stress
Cell growth
2,2'-dithiodiethanesulfonic acid

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Parker, A. R., Petluru, P. N., Nienaber, V. L., Badger, J., Leverett, B. D., Jair, K., ... Hausheer, F. H. (2015). Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787. Molecules, 20(3), 4928-4950. https://doi.org/10.3390/molecules20034928

Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787. / Parker, Aulma R.; Petluru, Pavankumar N.; Nienaber, Vicki L.; Badger, John; Leverett, Betsy D.; Jair, Kamwing; Sridhar, Vandana; Logan, Cheyenne; Ayala, Philippe Y.; Kochat, Harry; Hausheer, Frederick H.

In: Molecules, Vol. 20, No. 3, 01.03.2015, p. 4928-4950.

Research output: Contribution to journalArticle

Parker, AR, Petluru, PN, Nienaber, VL, Badger, J, Leverett, BD, Jair, K, Sridhar, V, Logan, C, Ayala, PY, Kochat, H & Hausheer, FH 2015, 'Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787', Molecules, vol. 20, no. 3, pp. 4928-4950. https://doi.org/10.3390/molecules20034928
Parker, Aulma R. ; Petluru, Pavankumar N. ; Nienaber, Vicki L. ; Badger, John ; Leverett, Betsy D. ; Jair, Kamwing ; Sridhar, Vandana ; Logan, Cheyenne ; Ayala, Philippe Y. ; Kochat, Harry ; Hausheer, Frederick H. / Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787. In: Molecules. 2015 ; Vol. 20, No. 3. pp. 4928-4950.
@article{c8ddcd1ae3974ce38189b3fea71cc3e0,
title = "Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787",
abstract = "Glutaredoxin (Grx), peroxiredoxin (Prx), and thioredoxin (Trx) are redoxin family proteins that catalyze different types of chemical reactions that impact cell growth and survival through functionally distinct intracellular pathways. Much research is focused on understanding the roles of these redoxin proteins in the development and/or progression of human diseases. Grx and Prx are overexpressed in human cancers, including human lung cancers. BNP7787 is a novel investigational agent that has been evaluated in previous clinical studies, including non-small cell lung cancer (NSCLC) studies. Herein, data from activity assays, mass spectrometry analyses, and X-ray crystallographic studies indicate that BNP7787 forms mixed disulfides with select cysteine residues on Grx and Prx and modulates their function. Studies of interactions between BNP7787 and Trx have been conducted and reported separately. Despite the fact that Trx, Grx, and Prx are functionally distinct proteins that impact oxidative stress, cell proliferation and disease processes through different intracellular pathways, BNP7787 can modify each protein and appears to modulate function through mechanisms that are unique to each target protein. Tumor cells are often genomically heterogeneous containing subpopulations of cancer cells that often express different tumor-promoting proteins or that have multiple dysregulated signaling pathways modulating cell proliferation and drug resistance. A multi-targeted agent that simultaneously modulates activity of proteins important in mediating cell proliferation by functionally distinct intracellular pathways could have many potentially useful therapeutic applications.",
author = "Parker, {Aulma R.} and Petluru, {Pavankumar N.} and Nienaber, {Vicki L.} and John Badger and Leverett, {Betsy D.} and Kamwing Jair and Vandana Sridhar and Cheyenne Logan and Ayala, {Philippe Y.} and Harry Kochat and Hausheer, {Frederick H.}",
year = "2015",
month = "3",
day = "1",
doi = "10.3390/molecules20034928",
language = "English (US)",
volume = "20",
pages = "4928--4950",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787

AU - Parker, Aulma R.

AU - Petluru, Pavankumar N.

AU - Nienaber, Vicki L.

AU - Badger, John

AU - Leverett, Betsy D.

AU - Jair, Kamwing

AU - Sridhar, Vandana

AU - Logan, Cheyenne

AU - Ayala, Philippe Y.

AU - Kochat, Harry

AU - Hausheer, Frederick H.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Glutaredoxin (Grx), peroxiredoxin (Prx), and thioredoxin (Trx) are redoxin family proteins that catalyze different types of chemical reactions that impact cell growth and survival through functionally distinct intracellular pathways. Much research is focused on understanding the roles of these redoxin proteins in the development and/or progression of human diseases. Grx and Prx are overexpressed in human cancers, including human lung cancers. BNP7787 is a novel investigational agent that has been evaluated in previous clinical studies, including non-small cell lung cancer (NSCLC) studies. Herein, data from activity assays, mass spectrometry analyses, and X-ray crystallographic studies indicate that BNP7787 forms mixed disulfides with select cysteine residues on Grx and Prx and modulates their function. Studies of interactions between BNP7787 and Trx have been conducted and reported separately. Despite the fact that Trx, Grx, and Prx are functionally distinct proteins that impact oxidative stress, cell proliferation and disease processes through different intracellular pathways, BNP7787 can modify each protein and appears to modulate function through mechanisms that are unique to each target protein. Tumor cells are often genomically heterogeneous containing subpopulations of cancer cells that often express different tumor-promoting proteins or that have multiple dysregulated signaling pathways modulating cell proliferation and drug resistance. A multi-targeted agent that simultaneously modulates activity of proteins important in mediating cell proliferation by functionally distinct intracellular pathways could have many potentially useful therapeutic applications.

AB - Glutaredoxin (Grx), peroxiredoxin (Prx), and thioredoxin (Trx) are redoxin family proteins that catalyze different types of chemical reactions that impact cell growth and survival through functionally distinct intracellular pathways. Much research is focused on understanding the roles of these redoxin proteins in the development and/or progression of human diseases. Grx and Prx are overexpressed in human cancers, including human lung cancers. BNP7787 is a novel investigational agent that has been evaluated in previous clinical studies, including non-small cell lung cancer (NSCLC) studies. Herein, data from activity assays, mass spectrometry analyses, and X-ray crystallographic studies indicate that BNP7787 forms mixed disulfides with select cysteine residues on Grx and Prx and modulates their function. Studies of interactions between BNP7787 and Trx have been conducted and reported separately. Despite the fact that Trx, Grx, and Prx are functionally distinct proteins that impact oxidative stress, cell proliferation and disease processes through different intracellular pathways, BNP7787 can modify each protein and appears to modulate function through mechanisms that are unique to each target protein. Tumor cells are often genomically heterogeneous containing subpopulations of cancer cells that often express different tumor-promoting proteins or that have multiple dysregulated signaling pathways modulating cell proliferation and drug resistance. A multi-targeted agent that simultaneously modulates activity of proteins important in mediating cell proliferation by functionally distinct intracellular pathways could have many potentially useful therapeutic applications.

UR - http://www.scopus.com/inward/record.url?scp=84929591375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929591375&partnerID=8YFLogxK

U2 - 10.3390/molecules20034928

DO - 10.3390/molecules20034928

M3 - Article

VL - 20

SP - 4928

EP - 4950

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 3

ER -